News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Daily News FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed L.A. McKeown July 11, 2023
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Daily News Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail L.A. McKeown April 22, 2021
News Daily News FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting L.A. McKeown June 10, 2019
News Daily News FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD L.A. McKeown March 15, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2018 Caitlin E. Cox January 01, 2019
Presentation Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease Presenter: Kenneth Rosenfield June 25, 2015